You can buy or sell FMS and other stocks, options, ETFs, and crypto commission-free!
Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. Read More It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Bad Homburg, Hessen
52 Week High
52 Week Low
Shareholders reproach Germany's Fresenius Medical Care after foreign bribery case
* Fresenius Medical Care AGM held on Thursday * Executive board gets approval rating of 56.81 pct * ISS recommends no confidence vote on U.S. bribery settlement BERLIN, May 16 (Reuters) - Fresenius Medical Care on Thursday became the latest German company to face a reproach from investors, with only a narrow majority of shareholders giving its top management and supervisory board their vote of approval. At the dialysis clinic operator’s annual general meeting, 56.81 percent of shareholders voted in favo...
Seeking AlphaMay 16
Fresenius Medical Care goes ex-dividend tomorrow
Fresenius Medical Care (NYSE:FMS) declares $0.452/share annual dividend. Payable May 31; for shareholders of record May 20; ex-div May 17. See FMS Dividend Scorecard, Yield Chart, & Dividend Growth....
PR NewswireMay 7
CytoSorbents Reports First Quarter 2019 Financial Results and Provides Second Quarter 2019 Guidance
MONMOUTH JUNCTION, N.J., May 7, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, reports financial and operational results for the quarter ending March 31, 2019. First Quarter 2019 Financial Results: Total revenue for Q1 2019 was $5.2 million , including both product sales and grant income, compared to $4.9 million...
Available Jul 30, Pre-Market